Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

S.J. Antonia ; A. Villegas ; D. Daniel ; D. Vicente ; S. Murakami ; R. Hui ; ... NEW ENGLAND JOURNAL OF MEDICINE, Vol.377(20) : 1919-1929, 2017
This table browses all dspace content
Issue DateTitleJournal Title
2024Clinical implication of electrocardiogram change in patients experiencing lung transplantation with end stage lung disease FRONTIERS IN PHYSIOLOGY
20242024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation JOURNAL OF ARRHYTHMIA
2024Distinctive CD39+CD9+ lung interstitial macrophages suppress IL-23/Th17-mediated neutrophilic asthma by inhibiting NETosis NATURE COMMUNICATIONS
2024Effectiveness of Early Thiopurine Use in Korean Patients With Moderate-to-Severe Ulcerative Colitis: A Prospective Multicenter Cohort (MOSAIK) StudyJOURNAL OF CLINICAL GASTROENTEROLOGY
2024A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer FUTURE ONCOLOGY
2024T-Cell Dynamics Predicts Prognosis of Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2024ASO Visual Abstract: Left Upper Division Segmentectomy Compared with Lobectomy for Lung Expansion and Bronchus TortuosityANNALS OF SURGICAL ONCOLOGY
2024Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple-negative breast cancer: Results from the triple-negative breast cancer cohort of the phase 2 LEAP-005 StudyCANCER
2024De novo versus recurrent metastatic breast cancer affects the extent of brain metastasesJOURNAL OF NEURO-ONCOLOGY
2024Geographical Variations in the Effectiveness and Safety of Abbreviated or Standard Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients at High Bleeding RiskCANADIAN JOURNAL OF CARDIOLOGY
2024Treatment extent of femoropopliteal disease and clinical outcomes following endovascular therapyEUROINTERVENTION
2024Pharmacokinetics, safety, and efficacy of an alternative dosing regimen of sasanlimab in participants with advanced NSCLC and other malignancies THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2024Customized Hydrogel Films for MicroRNA Super-Resolution Imaging in Liquid BiopsiesADVANCED HEALTHCARE MATERIALS
2024Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study BREAST CANCER
2024The position of loco-regional therapy in the management of hepatocellular carcinoma with extrahepatic metastases Journal of Liver Cancer(대한간암학회지)
2024Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trialLANCET ONCOLOGY
2024Impact of Serum Creatinine– and Cystatin C–Based Sarcopenia Index on Renal Outcomes in Non–Dialysis-Dependent Chronic Kidney Disease Patients: Results From the KNOW-CKD StudyMAYO CLINIC PROCEEDINGS
2024Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous Nephropathy KIDNEY INTERNATIONAL REPORTS
2024Factors associated with gastric and duodenal neuroendocrine tumors: A multicenter case-control studyDIGESTIVE AND LIVER DISEASE
2024Lactobacillus acidophilus KBL409 protects against kidney injury via improving mitochondrial function with chronic kidney diseaseEUROPEAN JOURNAL OF NUTRITION

Browse

Links